China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$0.07 -0.04 (-39.75%)
As of: Oct 20, 2026 · 3:59 PM EDT

China SXT Pharmaceuticals (SXTC) Other Working Capital Changes (2017 - 2019)

Updated

China SXT Pharmaceuticals' Other Working Capital Changes was -$69,551 in FY2026 (year ended Mar 31, 2026), compared with -$223,477 in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Other Working Capital Changes (2017 - 2019) Analysis & Trends

From FY2017 onward, China SXT Pharmaceuticals has reported Other Working Capital Changes for 10 fiscal years.

  • Annual Other Working Capital Changes has moved between -$360,860 (FY2022) and $143,175 (FY2024) over five years.
  • Per Business Quant data, Other Working Capital Changes in earlier fiscal years was -$223,477 in FY2025, $143,175 in FY2024, -$73,034 in FY2023 and -$360,860 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 China SXT Pharmaceuticals 567.53 -85.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -356,614.00
Dec 31, 2018 478,013.00
Dec 31, 2017 -217,456.00
API Access

China SXT Pharmaceuticals Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=SXTC&period=max&api_key=YOUR_API_KEY